Kaneka Aerospace acquires Henkel Corporation's composites portfolio
Kaneka Aerospace has acquired commercial rights, technologies and patents of benzoxazine based high performance composites business from Henkel Corp.
Share
Kaneka Corp.'s (Tokyo, Japan) wholly owned subsidiary, Kaneka Aerospace, LLC (KAE, Benicia, CA) and Henkel Corp. (Rocky Hill, CT) finalized the transfer of commercial rights, technologies and patents of benzoxazine based high performance composites business from Henkel Corp. to Kaneka Aerospace on January 30, 2018.
KAE was established in September 2017 with Kaneka Corp.'s acquisition of Applied Poleramic Inc. (API), which possessed advanced technology for formulated resin used in high performance composites, entering Kaneka Corp. into the aerospace business. The addition of Henkel's benzoxazine based composites business further strengthens KAE in the high performance composite products market.
Included in the acquisition are benzoxazine based prepregs, film adhesives, and infusion resins. Several of these products have been qualified in the Aviation Market.
Related Content
-
CompPair adds swift prepreg line to HealTech Standard product family
The HealTech Standard product family from CompPair has been expanded with the addition of CS02, a swift prepreg line.
-
VIDEO: One-Piece, OOA Infusion for Aerospace Composites
Tier-1 aerostructures manufacturer Spirit AeroSystems developed an out-of-autoclave (OOA), one-shot resin infusion process to reduce weight, labor and fasteners for a multi-spar aircraft torque box.
-
Bladder-assisted compression molding derivative produces complex, autoclave-quality automotive parts
HP Composites’ AirPower technology enables high-rate CFRP roof production with 50% energy savings for the Maserati MC20.
